pRSI9-U6-(sh)-UbiC-TagRFP-2A-Puro Citations (18)
Originally described in: DECIPHER library reagentsFrangou, G Unpublished
Articles Citing pRSI9-U6-(sh)-UbiC-TagRFP-2A-Puro
| Articles |
|---|
| Pmepa1 induced by RANKL-p38 MAPK pathway has a novel role in osteoclastogenesis. Funakubo N, Xu X, Kukita T, Nakamura S, Miyamoto H, Kukita A. J Cell Physiol. 2018 Apr;233(4):3105-3118. doi: 10.1002/jcp.26147. Epub 2017 Sep 20. PubMed |
| Inhibition of LINE-1 Retrotransposition by Capsaicin. Nishikawa Y, Nakayama R, Obika S, Ohsaki E, Ueda K, Honda T. Int J Mol Sci. 2018 Oct 19;19(10). pii: ijms19103243. doi: 10.3390/ijms19103243. PubMed |
| Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption. Xu X, Hirata H, Shiraki M, Kamohara A, Nishioka K, Miyamoto H, Kukita T, Kukita A. FASEB J. 2019 Mar;33(3):4365-4375. doi: 10.1096/fj.201801573R. Epub 2018 Dec 17. PubMed |
| Deficiency of stress-associated gene Nupr1 increases bone volume by attenuating differentiation of osteoclasts and enhancing differentiation of osteoblasts. Shiraki M, Xu X, Iovanna JL, Kukita T, Hirata H, Kamohara A, Kubota Y, Miyamoto H, Mawatari M, Kukita A. FASEB J. 2019 Aug;33(8):8836-8852. doi: 10.1096/fj.201802322RR. Epub 2019 May 8. PubMed |
| PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation. Yu J, Xu H, Cui J, Chen S, Zhang H, Zou Y, Zhao J, Le S, Jiang L, Chen Z, Liu H, Zhang D, Xia J, Wu J. Aging (Albany NY). 2020 Jun 15;12(12):11636-11652. doi: 10.18632/aging.103330. Epub 2020 Jun 15. PubMed |
| Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Zhang H, Nakauchi Y, Kohnke T, Stafford M, Bottomly D, Thomas R, Wilmot B, McWeeney SK, Majeti R, Tyner JW. Nat Cancer. 2020 Aug;1(8):826-839. doi: 10.1038/s43018-020-0103-x. Epub 2020 Aug 18. PubMed |
| Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence. Garnett S, de Bruyns A, Provencher-Tom V, Dutchak K, Shu R, Dankort D. Mol Cancer Res. 2021 May;19(5):874-885. doi: 10.1158/1541-7786.MCR-20-0879. Epub 2021 Jan 26. PubMed |
| Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation. Heckler M, Ali LR, Clancy-Thompson E, Qiang L, Ventre KS, Lenehan P, Roehle K, Luoma A, Boelaars K, Peters V, McCreary J, Boschert T, Wang ES, Suo S, Marangoni F, Mempel TR, Long HW, Wucherpfennig KW, Dougan M, Gray NS, Yuan GC, Goel S, Tolaney SM, Dougan SK. Cancer Discov. 2021 Oct;11(10):2564-2581. doi: 10.1158/2159-8290.CD-20-1540. Epub 2021 May 3. PubMed |
| Leukemia/lymphoma-related factor (LRF) or osteoclast zinc finger protein (OCZF) overexpression promotes osteoclast survival by increasing Bcl-xl mRNA: A novel regulatory mechanism mediated by the RNA binding protein SAM68. Xu X, Shobuike T, Shiraki M, Kamohara A, Hirata H, Murayama M, Mawatari D, Ueno M, Morimoto T, Kukita T, Mawatari M, Kukita A. Lab Invest. 2022 Sep;102(9):1000-1010. doi: 10.1038/s41374-022-00792-w. Epub 2022 Apr 26. PubMed |
| Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. Thomas D, Wu M, Nakauchi Y, Zheng M, Thompson-Peach CAL, Lim K, Landberg N, Kohnke T, Robinson N, Kaur S, Kutyna M, Stafford M, Hiwase D, Reinisch A, Peltz G, Majeti R. Cancer Discov. 2023 Feb 6;13(2):496-515. doi: 10.1158/2159-8290.CD-21-0218. PubMed |
| A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. Floerchinger A, Klein JE, Finkbeiner MSC, Schafer TE, Fuchs G, Doerner J, Zirngibl H, Ackermann M, Kvasnicka HM, Chester KA, Jager D, Ball CR, Ungerechts G, Engeland CE. Cell Death Dis. 2023 Feb 10;14(2):104. doi: 10.1038/s41419-023-05624-3. PubMed |
| Evolution of Resistance to Irinotecan in Cancer Cells Involves Generation of Topoisomerase-Guided Mutations in Non-Coding Genome That Reduce the Chances of DNA Breaks. Kumar S, Gahramanov V, Patel S, Yaglom J, Kaczmarczyk L, Alexandrov IA, Gerlitz G, Salmon-Divon M, Sherman MY. Int J Mol Sci. 2023 May 13;24(10):8717. doi: 10.3390/ijms24108717. PubMed |
| The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability. Ravn-Boess N, Roy N, Hattori T, Bready D, Donaldson H, Lawson C, Lapierre C, Korman A, Rodrick T, Liu E, Frenster JD, Stephan G, Wilcox J, Corrado AD, Cai J, Ronnen R, Wang S, Haddock S, Sabio Ortiz J, Mishkit O, Khodadadi-Jamayran A, Tsirigos A, Fenyo D, Zagzag D, Drube J, Hoffmann C, Perna F, Jones DR, Possemato R, Koide A, Koide S, Park CY, Placantonakis DG. Cell Rep. 2023 Nov 28;42(11):113374. doi: 10.1016/j.celrep.2023.113374. Epub 2023 Nov 8. PubMed |
| Metformin reduces the clonal fitness of Dnmt3a(R878H) hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic state. Hosseini M, Voisin V, Chegini A, Varesi A, Cathelin S, Ayyathan DM, Liu ACH, Yang Y, Wang V, Maher A, Grignano E, Reisz JA, D'Alessandro A, Young K, Wu Y, Fiumara M, Ferrari S, Naldini L, Gaiti F, Pai S, Schimmer AD, Bader GD, Dick JE, Xie SZ, Trowbridge JJ, Chan SM. Res Sq [Preprint]. 2024 Feb 6:rs.3.rs-3874821. doi: 10.21203/rs.3.rs-3874821/v1. PubMed |
| Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia. Yanagiya R, Miyatake Y, Watanabe N, Shimizu T, Kanamori A, Ueno M, Okabe S, Carreras J, Nakayama S, Hasegawa A, Kameda K, Kamakura T, Nakagawa S, Yamauchi T, Maeda T, Ishii K, Matsuura T, Handa H, Hirao A, Ishizawa K, Onizuka M, Mashima T, Nakamura N, Ando K, Kotani A. Leukemia. 2024 Aug;38(8):1731-1741. doi: 10.1038/s41375-024-02296-6. Epub 2024 Jun 24. PubMed |
| P-stalk ribosomes act as master regulators of cytokine-mediated processes. Dopler A, Alkan F, Malka Y, van der Kammen R, Hoefakker K, Taranto D, Kocabay N, Mimpen I, Ramirez C, Malzer E, Isaeva OI, Kerkhoff M, Gangaev A, Silva J, Ramalho S, Hoekman L, Altelaar M, Beijersbergen R, Akkari L, Yewdell JW, Kvistborg P, Faller WJ. Cell. 2024 Nov 27;187(24):6981-6993.e23. doi: 10.1016/j.cell.2024.09.039. Epub 2024 Oct 21. PubMed |
| TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling. Yang Y, Cathelin S, Liu ACH, Subedi A, Maher A, Hosseini M, Manikoth Ayyathan D, Vanner R, Chan SM. Nat Commun. 2025 Mar 10;16(1):2384. doi: 10.1038/s41467-025-57614-y. PubMed |
| Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia. Kuchler S, Brilloff S, Schafer S, Rahimian E, Kufrin V, Peri SS, Musa J, Grunewald TGP, Schewe DM, Ball CR, Bornhauser M, Glimm H, Bill M, Wurm AA. Cell Death Discov. 2025 Oct 20;11(1):470. doi: 10.1038/s41420-025-02810-4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.